Principal, New Product Planning, BioMarketing Insight
Regina Au is Principal, New Product Planning/Strategic Planning Consultant at BioMarketing Insight with 20+ years experience in the biotechnology, pharmaceutical, medical device, diagnostic and healthcare industries. She helps companies to maximize the benefits of their technology by conducting the business due diligence early in product development to de-risk the process and increase commercial success. This ensures that the technology is the right product for the right market in meeting a critical unmet need and that the market opportunity for the product meets the business goals of the company. She will translate these unmet needs into a target product profile (TPP) or commercial profile. Ms. Au then develops marketing strategies to ensure market access and product adoption.
Ms. Au is a member of the Advisory Board for Regis College Master of Regulatory and Clinical Research Management Program. She also serves as an advisor for the Massachusetts Technology Transfer Center Platform Meetings for entrepreneurs. She is an Adjunct Professor at Northeastern University in the Masters in Biotechnology Program and at Regis College in the Master of Regulatory and Clinical Research Management Program.
She is a member of the Editorial Board for the International Journal of Clinical Pharmacology & Pharmacotherapy and Industry Advisor for the European BioPharmaceutical Review Journal and has published numerous articles on market and technology trends such as Immuno-oncology: CAR-T; Genetic Engineering to Genome Engineering; Microbiome; and Alzheimer's Disease Pathology.
Prior to BioMarketing Insight she worked for companies such as Merck & Co., Genzyme Corp., NMT Medical, and Radi Medical (St. Jude Medical) in various positions of increasing responsibility in new product planning, marketing and sales. She had P&L responsibility in managing six multimillion dollar product lines and has experience in upstream and downstream marketing.